CEST MRI monitoring of tumor response to vascular disrupting therapy using high molecular weight dextrans-Reference-Cited by-同舟云学术

CEST MRI monitoring of tumor response to vascular disrupting therapy using high molecular weight dextrans

Author:

Chen Hanwei¹²,Liu Dexiang¹²,Li Yuguo²³,Xu Xiang²³,Xu Jiadi²³,Yadav Nirbhay N.²³,Zhou Shibin⁴,Zijl Peter C. M.²³,Liu Guanshu²³^ORCID

Affiliation:

1. Department of Radiology Guangzhou Panyu Central Hospital Guangzhou Guangdong China

2. Russell H. Morgan Department of Radiology and Radiological Science Johns Hopkins University School of Medicine Baltimore Maryland

3. F.M. Kirby Research Center for Functional Brain Imaging Kennedy Krieger Institute Baltimore Maryland

4. Ludwig Center Howard Hughes Medical Institute and Sidney Kimmel Cancer Center, Johns Hopkins University School of Medicine Baltimore Maryland

Funder

Virginia and D.K. Ludwig Fund for Cancer Research

National Institutes of Health

Publisher

Wiley

Subject

Radiology, Nuclear Medicine and imaging

Link

Reference53 articles.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献